CLDX - Celldex Therapeutics, Inc.


29.43
0.070   0.238%

Share volume: 673,265
Last Updated: 03-06-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$29.36
0.07
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-06-2024 08-08-2024 11-06-2024 02-27-2025 05-08-2025 08-07-2025 11-10-2025 02-25-2026
Cash flow financing 436.112 M 3.712 M 1.239 M 386.000 K 202.000 K 63.000 K 774.000 K 1.349 M
Other financing cash flows 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Cash flow 80.263 M -72.338 M -6.340 M -8.043 M -11.220 M 5.908 M 12.993 M -7.166 M
Net income -32.808 M -35.842 M -42.121 M -47.092 M -53.796 M -56.600 M -67.044 M -81.317 M
Depreciation 775.000 K 797.000 K 786.000 K 819.000 K 867.000 K 873.000 K 824.000 K 816.000 K
Changes in inventories 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Changes in receivables 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Cashflow -315.211 M -46.723 M 47.758 M 24.047 M 42.950 M 49.850 M 60.847 M 55.425 M
Net Borrowings 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Activity Other -105.000 K 88.000 K -215.000 K 205.000 K 0.000 0.000 -423.000 K 374.000 K
Dividends Paid 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Exchange Rate Effect 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Capital Expenditures 344.000 K 274.000 K 545.000 K 756.000 K 265.000 K 728.000 K 440.000 K 1.281 M
Cash Change 80.263 M -72.338 M -6.340 M -8.043 M -11.220 M 5.908 M 12.993 M -7.166 M